SCHEMBL5217671

SCHEMBL5217671

CCN1CCNc2c(NC(=O)CCCCl)cc(C(=O)OC)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.36
PKM P14618 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TSHR P16473 3/20 0.36
KDM4E B2RXH2 5/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.33
MDH1 P40925 1/20 0.33
MDH2 P40926 1/20 0.33
ATM Q13315 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219254 0.76 KDM4E (0.42) ALDH1A1TDP1TSHRKDM4EHSD17B10
SCHEMBL5306835 0.76 TP53 (0.32)
SCHEMBL5220005 0.76 TP53 (0.30)
SCHEMBL5224165 0.73 ALDH1A1 (0.47) ALDH1A1PKMTDP1TSHRKDM4E
SCHEMBL5222005 0.72 MAPT (0.44) ALDH1A1TDP1KDM4EHPGDKMT2A
SCHEMBL5217023 0.72 ALDH1A1 (0.46) ALDH1A1PKMTDP1TSHRKDM4E
SCHEMBL5225585 0.72 CYP2C9 (0.38) ALDH1A1TDP1TSHRHSD17B10HPGD
SCHEMBL5221511 0.69 ALDH1A1 (0.39) ALDH1A1PKMTDP1TSHRKDM4E
SCHEMBL5221827 0.69 KDM4E (0.41) ALDH1A1PKMTDP1TSHRKDM4E
SCHEMBL475604 0.68 ALDH1A1 (0.53) ALDH1A1PKMTDP1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed